<PRE>
[Federal Register: May 24, 2001 (Volume 66, Number 101)]
[Notices]               
[Page 28754]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24my01-75]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Pediatric Oncology Subcommittee of the Oncologic 
Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 28, 2001, 8 a.m. to 
5 p.m.
    Location: Center for Drug Evaluation and Research Advisory 
Committee conference room 1066, 5630 Fishers Lane, Rockville, MD.
    Contact Person: Karen M. Templeton-Somers, Center for Drug 
Evaluation and Research, (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, or by e-mail: 
<A HREF="mailto:SomersK@cder.fda.gov">SomersK@cder.fda.gov</A>, or FDA Advisory Committee Information Line, 1-
800-741-8138 (301-443-0572 in the Washington, DC area), code 12542. 
Please call the Information Line for up-to-date information on this 
meeting.
    Agenda: The subcommittee will discuss parameters used for 
extrapolation from the adult to the pediatric setting in solid tumors 
and malignancies of the central nervous system.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the subcommittee. 
Written submissions may be made to the contact person by June 18, 2001. 
Oral presentations from the public will be scheduled between 
approximately 8:15 a.m. and 8:45 a.m., and 1 p.m. and 1:30 p.m. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before June 
18, 2001, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 17, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-13168 Filed 5-23-01; 8:45 am]
BILLING CODE 4160-01-S

</PRE>